60 related articles for article (PubMed ID: 14646353)
1. Pharmacokinetics and the cardiovascular effects of irbesartan in aortic coarctated rats.
Höcht C; Opezzo JA; Taira CA
Pharmacology; 2004 Jan; 70(1):23-30. PubMed ID: 14646353
[TBL] [Abstract][Full Text] [Related]
2. Hypothalamic antihypertensive effect of irbesartan in chronic aortic coarctated rats.
Höcht C; Opezzo JA; Taira CA
Pharmacology; 2005 Mar; 73(3):146-54. PubMed ID: 15564789
[TBL] [Abstract][Full Text] [Related]
3. Study of the hypothalamic angiotensin system in aortic coarctated rats using the reverse microdialysis technique.
Höcht C; Opezzo JA; Gironacci M; Peña C; Taira CA
Pharmacol Res; 2003 Sep; 48(3):301-7. PubMed ID: 12860451
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic alterations of methyldopa in rats with aortic coarctation. A study using microdialysis.
Höcht C; Opezzo JA; Gorzalczany SB; Priano RM; Bramuglia GF; Taira CA
Pharmacol Res; 2001 Nov; 44(5):377-83. PubMed ID: 11712868
[TBL] [Abstract][Full Text] [Related]
5. Hypothalamic antihypertensive effect of metoprolol in chronic aortic coarctated rats.
Höcht C; Opezzo JA; Taira CA
Clin Exp Pharmacol Physiol; 2005 Aug; 32(8):681-6. PubMed ID: 16120197
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic-pharmacodynamic properties of metoprolol in chronic aortic coarctated rats.
Höcht C; Di Verniero C; Opezzo JA; Taira CA
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):1-8. PubMed ID: 15300360
[TBL] [Abstract][Full Text] [Related]
7. Applicability of microdialysis as a technique for pharmacokinetic-pharmacodynamic (PK-PD) modeling of antihypertensive beta-blockers.
Höcht C; DiVerniero C; Opezzo JA; Taira CA
J Pharmacol Toxicol Methods; 2005; 52(2):244-50. PubMed ID: 16125622
[TBL] [Abstract][Full Text] [Related]
8. Anterior hypothalamic beta-adrenoceptors in chronic aortic-coarctated hypertensive rats: an interaction with central angiotensin II receptors.
Höcht C; Opezzo JA; Gironacci MM; Peña C; Taira CA
Clin Exp Pharmacol Physiol; 2005; 32(1-2):30-4. PubMed ID: 15730431
[TBL] [Abstract][Full Text] [Related]
9. Increased sensitivity to diltiazem hypotensive effect in an experimental model of high-renin hypertension.
Bertera FM; Mayer MA; Opezzo JA; Taira CA; Höcht C
J Pharm Pharmacol; 2009 Jan; 61(1):79-87. PubMed ID: 19126300
[TBL] [Abstract][Full Text] [Related]
10. Anterior hypothalamic beta-adrenergic activity in the maintenance of hypertension in aortic coarctated rats.
Höcht C; Opezzo JA; Taira CA
Pharmacol Res; 2004 Jan; 49(1):17-21. PubMed ID: 14597147
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different pharmacodynamic models for PK-PD modeling of verapamil in renovascular hypertension.
Bertera FM; Mayer MA; Opezzo JA; Taira CA; Höcht C
J Pharmacol Toxicol Methods; 2008; 57(3):212-9. PubMed ID: 18442930
[TBL] [Abstract][Full Text] [Related]
12. Validation of a new intraarterial microdialysis shunt probe for the estimation of pharmacokinetic parameters.
Höcht C; Opezzo JW; Taira C
J Pharm Biomed Anal; 2003 Apr; 31(6):1109-17. PubMed ID: 12667927
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic study of methyldopa in aorta-coarctated rats using a microdialysis technique.
Opezzo JA; Höcht C; Taira CA; Bramuglia GF
Pharmacol Res; 2001 Feb; 43(2):155-9. PubMed ID: 11243717
[TBL] [Abstract][Full Text] [Related]
14. Disposition of irbesartan, an angiotensin II AT1-receptor antagonist, in mice, rats, rabbits, and macaques.
Davi H; Tronquet C; Miscoria G; Perrier L; DuPont P; Caix J; Simiand J; Berger Y
Drug Metab Dispos; 2000 Jan; 28(1):79-88. PubMed ID: 10611144
[TBL] [Abstract][Full Text] [Related]
15. Influence of Single and Multi Dose Treatment of Glipizide on Pharmacokinetics and Pharmacodynamics of Irbesartan in Normal and Hypertensive Rats.
Anusha A; Narendar D; Krishna Murthy B; Goverdhan P
High Blood Press Cardiovasc Prev; 2017 Jun; 24(2):179-185. PubMed ID: 28386752
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic-pharmacodynamic modeling of diltiazem in spontaneously hypertensive rats: a microdialysis study.
Bertera FM; Mayer MA; Opezzo JA; Taira CA; Bramuglia GF; Höcht C
J Pharmacol Toxicol Methods; 2007; 56(3):290-9. PubMed ID: 17560132
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro pharmacodynamic properties of metoprolol in aortic coarctated rats.
Höcht C; Di Verniero C; Opezzo JA; Taira CA
Pharmacol Res; 2003 Mar; 47(3):181-8. PubMed ID: 12591012
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics and pharmacodynamics of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) in the dog.
Christ DD; Wong PC; Wong YN; Hart SD; Quon CY; Lam GN
J Pharmacol Exp Ther; 1994 Mar; 268(3):1199-205. PubMed ID: 8138932
[TBL] [Abstract][Full Text] [Related]
19. Human pharmacokinetic/pharmacodynamic profile of irbesartan: a new potent angiotensin II receptor antagonist.
Ruilope L
J Hypertens Suppl; 1997 Dec; 15(7):S15-20. PubMed ID: 9532516
[TBL] [Abstract][Full Text] [Related]
20. Effects of clonidine on the experimental hypertension by abdominal aortic coarctation in rats.
Gorzalczany SB; Opezzo JA; del Carmen Garcia M; Taira CA
Pharmacol Res; 2003 Jul; 48(1):17-24. PubMed ID: 12770510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
